130116-03-9

Basic information

• Product Name: 2,6-di(tert-butyl)-4-(5-sulfanyl-1,3,4-thiadiazol-2-yl)benzenol
• Synonyms: 2,6-di(tert-butyl)-4-(5-sulfanyl-1,3,4-thiadiazol-2-yl)benzenol
• CAS NO: 130116-03-9
• Molecular Formula: C₁₆H₂₂N₂OS₂
• Molecular Weight: 322.49
• Mol File: 130116-03-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,6-di(tert-butyl)-4-(5-sulfanyl-1,3,4-thiadiazol-2-yl)benzenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-di(tert-butyl)-4-(5-sulfanyl-1,3,4-thiadiazol-2-yl)benzenol(130116-03-9)
• EPA Substance Registry System: 2,6-di(tert-butyl)-4-(5-sulfanyl-1,3,4-thiadiazol-2-yl)benzenol(130116-03-9)

Safety Data

• Hazardous Substances Data: 130116-03-9(Hazardous Substances Data)

Upstream product

• 130116-74-4 3,5-bis(1,1-dimethylethyl)-4-<(2-methoxyethoxy)methoxy>benzenecarboximidic acid hydrazide 
• 130116-73-3 3,5-bis(1,1-dimethylethyl)-4-<(2-methoxyethoxy)methoxy>benzonitrile 
• 148773-27-7 3,5-bis(1,1-dimethylethyl)-4-methoxybenzenecarboximidic acid hydrazide 
• 130116-79-9 3,5-bis(1,1-dimethylethyl)-N,4-dihydroxybenzenecarboximidic acid hydrazide 
• 4917-29-7 3,5-di(tertbutyl)-4-methoxybenzonitrile 
• 1988-88-1 2,6-di-tert-butyl-4-cyanophenol 
• 787-13-3 3,5-di-tert-butyl-4-hydroxybenzaldehyde oxime 
• 130116-75-5 5-<3,5-bis(1,1-dimethylethyl)-4-<(2-methoxyethoxy)methoxy>phenyl>-1,3,4-thiadiazole-2(3H)-thione 
• 148773-28-8 5-<3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl>-1,3,4-thiazole-2(3H)-thione 
• 75-15-0 carbon disulfide 
• 130116-80-2 3,5-bis(1,1-dimethylethyl)-N,4-dihydroxybenzenecarboximidic acid hydrazide 
• 3202-96-8 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenecarbothionic acid, hydrazide 

Downstream Products

• 130116-26-6 2,6-Di-tert-butyl-4-(5-methylsulfanyl-[1,3,4]thiadiazol-2-yl)-phenol 

Relevant articles and documents

Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, - 1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents

To discover dual inhibitors of 5-lipoxygenase (LO) and cyclooxygenase (CO) with improved pharmacokinetic properties, we have designed and synthesized series of 1,2,4-triazole, 1,3,4-oxadiazole, and 1,3,4-thiadiazole di-tert- butylphenol derivatives which